http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112704740-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112704740-B |
| titleOfInvention | Montelukast resin composite and its preparation method and application |
| abstract | The present invention relates to a montelukast resin compound and its preparation method and application. The preparation method of the montelukast resin composite comprises the following steps: dissolving montelukast sodium in water to prepare a montelukast sodium solution; and after mixing and reacting the montelukast sodium solution with an anion resin, solid-liquid The montelukast resin complex is prepared by separating, drying, crushing and sieving. The above-mentioned montelukast resin compound can improve the dissolution rate, stability and uniformity of the anti-asthma drug using montelukast as an active ingredient. |
| priorityDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.